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Objectives: To evaluate the effect of the presence of pathogenic bacteria in urine on three
bladder cancer genetic markers (Cytokeratin 19, Cytokeratin 20 and Uroplakin II mRNA),
and to evaluate the reliability of each urine marker separately.
Methods: Voided urine samples from 20 bladder cancer patients, 15 patients with urinary
tract infection patients and 10 healthy volunteers were collected. Isolation and identifi-
cation of bacteria was performed followed by determination of antimicrobial susceptibility
of isolates. Evaluation of CK-19, CK-20 and UPII mRNA in urine by RT-PCR was carried out.
Results: The most frequent organism isolated was Escherichia coli followed by Klebsiella
pneumoniae. The overall sensitivity and specificity were 47.37% and 68.42%% for CK-19,
57.89% and 100% for CK-20 and 63.1% and 100%for UPII. Combined sensitivity and speci-
ficity of CK-20 and UPII biomarkers together was higher than that of each biomarker alone
or even more than that of the three combined biomarkers.
Conclusions: E. coli is the most predominant bacteria isolated from bladder cancer patients.
Both CK-20 and UPII have different expression levels for both benign and malignant cases.
Combined use of UPII and CK-20 may be a promising noninvasive tool for the detection of
bladder cancer in urine for patients who have both symptoms of UTI and cancer.
Copyright 2015, Mansoura University. Production and hosting by Elsevier B.V. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).1. Introduction
Bladder cancer (BC) is the most common cancer of the urinary
tract with around 380,000 new cases and 150,000 deaths per
year worldwide [1]. It has a five times higher prevalence(A. El Shobaky).
ra University.
sity. Production and hosti
licenses/by-nc-nd/4.0/).among men than women, and the median age at diagnosis is
65 years [2]. Risk factors associated with the development of
BC include carcinogens in tobacco smoke, exposures of
occupational origin, urinary tract infections, drinking tap
water and certain drugs such as cyclophosphamide. Bladder
cancer can sometimes cause microscopic or gross hematuriang by Elsevier B.V. This is an open access article under the CC BY-
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often than usual and pain or burning during urination. These
symptoms are also more likely to be caused by a benign con-
dition such as urinary tract infection and bladder stones.
Urinary tract infection (UTI) is one of the commonest in-
fections to affect humans. Under normal circumstances the
urinary tract is sterile and infection develops only when bac-
terial virulence overcomes normal host defense mechanisms.
UTI ismost commonly bacterial, but fungal, viral and parasitic
infections can occur [3]. Several authors around the world
have been reported the Gram negative bacteria of Escherichia
coli and Klebsiella spp. being the most frequent organisms
causing UTIs [4e6]. It is estimated that 20%e25% of all human
cancers are caused by chronic infection and inflammation. E.
coli infectionmight play a role in bladder cancer development,
as cancer might be mediated by activation of NF-kB family of
transcription factors, that regulates transcription of pro-
inflammatory cytokines genes, adhesion molecules and the
expression of several pro-survival genes resulting in inhibi-
tion of apoptosis and increased inflammation [7]. This also
may be due to, small amounts of nitrosamines, which may be
produced during infection and could initiate neoplastic or pre-
neoplastic changes in the urothelium.
Screening for bladder cancer, in patients with previous
symptoms to look for different substances or cancer cells in
the urine is currently done with urinalysis, urinary cytology
and cystoscopy [8].
Urinalysis is performed to check for blood in the urine or
hematuria. However, up to 25% of bladder cancer patients
may not have hematuria, even when they have a known
bladder tumor [8,9]. Urine cytology is a microscopic exami-
nation for urine samples to search for any cancer or pre-
cancer cells. Cytology has low sensitivity and specificity,
particularly for low-grade tumors, its results are not available
immediately and are interpreter dependent [10]. Cystoscopy is
a technique that enables visualization of the bladder lining
and biopsy of suspicious lesions for histopathological diag-
nosis and staging, but it is invasive, relatively expensive and
uncomfortable for the patients [11].
Thegold standard for initial clinical diagnosisof BC remains
cystoscopic examination of the bladder coupled with voided
urine cytology. High attention is focused on bladder cancer
early detection and followup using urinemarkers. Themarker
must be sensitive and specific to detect free cancer cell in urine
and quantitatively describing cancer progression [10e14].
Cytokeratins are epithelium-specific intermediate fila-
ments, expressed in various combinations, depending on the
epithelial type and degree of differentiation, which may be
useful in tumor diagnosis. One of these is cytokeratin-19. “CK-
19”which is expressed in epitheliumof the bladder. CYFRA 21-
1, whichmeasures fragments of cytokeratin 19, has even been
used as a prognostic and diagnosticmarker for transitional cell
carcinoma of the bladder [15]. Another cytokeratin is “CK-20”,
which is expressed in urothelium of the bladder cancer pa-
tients. It can be considered as a marker of urothelial differen-
tiation [8]. However, despite the fact that malignant cells
generally retain the intermediate filaments of the progenitor,
normal cells do not express the CK-20 gene. These findings
emphasize the possibility that CK-20 is a specific marker for
detecting bladder carcinoma [15]. On the other hand,Uroplakins are the integral protein subunits of the urothelial
plaques. One of these uroplakins is uroplakin II (UP-II). It is
readily detected by immunohistochemistry in urothelial car-
cinomas, but not in non-urothelial tumors [16,17]. UPII
expression is not strictly correlative with low pathological
grade, despite its being the terminal differentiationproducts of
normal urothelium [18]. So, UP-II can be an excellent marker
particularly when combined with other urothelium-restricted
markers in the differential diagnosis of bladder cancer [19].
In our work we focused on three urine markers “cytoker-
atin-20, cytokeratin-19 and Uroplakin II”, and the effect of
pathogenic bacteria on their reliability.2. Materials and methods
2.1. Urine collection
Two early morning voided urine samples of about 50e100 ml
were collected from 20 bladder cancer and 15 UTI patients
admitted to the Urology and Nephrology Center, Mansoura
University and from ten normal volunteers. These samples
were collected in sterile tightly locked containers after aseptic
precautions during obtaining the samples. One sample was
collected for bacterial culture, the other was obtained for
quantification of gene expression using Real Time PCR.
2.2. Bacterial identification and antimicrobial
susceptibility
The collected sampleswere cultured on C.L.E.D agar and blood
agar media (OXOID, ENGLAND). Smears of the isolated bac-
teria were stained with gram stain and were examined for
morphology and arrangement. Bacterial identification and
characterization of the most dominant isolates from the
samples using automated VITEK 2 according to manufactory
instructions were carried out (bioMerieux, Marcy I'Etoile,
France) [20].
The identification card for gram-negative bacilli (ID-GNB
card) was done by a 64-well plastic card containing 41 fluo-
rescent biochemical tests, including 18 enzymatic tests for
amino peptidases and oxidases. The card was inserted in the
VITEK 2 reader-incubator module (incubation temperature,
35.5 C), and was automatically subjected to a kinetic fluo-
rescence measurement every 15 min. The results were inter-
preted by the ID-GNB database after the incubation period
about 3 h. According to Shaaban, Ghozlan [21] the antimicro-
bial susceptibility tests of the identified bacterial isolates were
carried out using VITEK 2 antibiotic susceptibility panel cards.
2.3. Real time PCR
Urine sample was centrifuged for 10 min at 400  g in cold
conditions (2e8 C). The sedimentwas preserved in 200 ml RNA
Later solution (Qiagen Sciences, Maryland, USA) at 196 C for
further RNA extraction [22]. Total RNA was extracted from
urine cells for all the samples according to the protocol
employed Trizol (Invitrogen, USA). Then RNA purification
using ZYMOResearch urine RNA isolation kit (Zymo Research,
USA). Purified RNA was stored at 196 C. RNA concentration
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its integrity was determined by 1.5% agarose gel electropho-
resis and ethidium bromide staining. Only samples that were
observed two RNA characteristic bands and were not
degradable were used for real-time PCR (RT-PCR).
1 mg of total RNA was converted into single-stranded
complementary deoxyribonucleic acid (cDNA) by random
priming using RT First strand kit (Qiagen Sciences, Maryland,
USA). Gene expression was performed separately for CK19,
CK-20 and UPII using quantitative polymerase chain reaction
(qPCR). PCR analysis. В-actin was used as housekeeping gene.
Each amplification was performed for 40 cycles; a cycle profile
consisted of denaturation at 94 C for 20 s, annealing at 58 C
for 30 s, extension at 60 C for 30 s. Sequences of the primers
used are designed from NCBI as shown in Table 1.
Amplifications were performed by using a 25 mL total re-
action volume contains 25 pmole of each primer, 3 mL of cDNA
template, 12.5 mL 2 SYBR Green Rox Master Mix (Qiagen
Sciences, Maryland, USA) and adjusted volume by nuclease-
free water. The plate was inserted in real time thermal
cycler (ABI PRISM 7000, Applied Biosystem, California, USA).
For each sample, the procedure was carried out in triplicate. A
mathematical model introduced by Pfaffl was used for the
relative quantification of target genes [23].2.4. Statistical analysis
Studying the difference of gene expression for urine samples
between the three groups, and the relation between bacterial
barcodes for samples and percentage of gene expression was
performed. All analyses were performed using the Statistical
Package for the Social Sciences (SPSS) (SPSS, Chicago, IL, USA).
ROC and KaplaneMeier analysis were used to determine the
cut off level of CK-19 CK-20 and UPII mRNA expression. The
nonparametric Mann Whitney rank, Pearson, Spearman,
Anova, Kruskal and sum U test were used for the statistical
comparison of the variables between the various groups. The
level of significance was determined to be less than 0.05.3. Results
Among 20 bladder cancer patients, there were ten and three
patients infected with E. coli and Klebsiella pneumonia, respec-
tively. Out of the 15 patients with UTI, 13 were infected with E.
coli and 2 with Klebsiella pneumoniae. Antibiotic susceptibility
results indicated that all E. coli isolates were sensitive to imi-
penem and amikacin (resistance 0%). The resistance rates of
other antibiotics were: amoxicillin/clavulanate 88% (24/27),Table 1 e List of gene-specific primers in RT-PCR.
Genes Forward primer R
CK-19 TGCGGGACAAGATTCTTGGT TCTCAA
CK-20 CTGATGCAGATTCGGAGTAACA TCTCTC
UPII GCATACCAGGTGACAAACCTC GTTCCT
B-Actin AGGCACCAGGGCGTGAT GCCCACtrimethoprim/sulphamethoxazole 81% (22/27), ciprofloxacin
77% (21/27), cefotaxime and ceftazidime 62% (17/27), nitro-
furantoin 40% (11/27), piperacillin/tazobactam 19% (5/27). All
K. pneumoniae isolates were sensitive to imipenem, amikacin
and piperacillin/tazobactam 100% (5/5), while the resistance
rates were 60% (3/5) for cefotaxime, ceftazidime, trimetho-
prim/sulphamethoxazole, ciprofloxacin and ciprofloxacin.
The resistance rate was 40% (2/5) for amoxicillin/clavulanate.
The expression levels for CK-19, CK-20 and UPII mRNA in
the voided urine samples of the bladder tumor were 9/19
(47%), 11/19 (58%), and 12/19 (63%), respectively as shown in
Table 2. There was statistical significance (p < 0.05) in UPII and
CK20 expression level between groups; while there was no
statistical significance (p > 0.05) in CK19 expression level be-
tween groups. So, presence of pathogenic bacteria may affect
the reliability of CK19marker for bladder cancer diagnosis, but
has no effect on UPII and CK20 results. Fig. 1 shows different
expression levels of В-actin, CK-19, CK-20 and UPII mRNA in
study groups.3.1. Sensitivity and specificity of CK-19, CK-20 and UPII
RT-PCR
As shown in Table 3, the overall sensitivity and specificity
were 47.37% and 68.42% for CK-19, 58% and 100%for CK-20,
and 63.1% and 100% for UPII. The sensitivity and specificity of
the combined use of CK-20 and UPII were (79%) and (100%),
respectively. The latter rates were higher than those for each
marker alone and were also higher than the rates for the
combination of the three markers. The negative predictive
value was 60%, 100% and 100% for CK-19, CK-20 and UPII,
respectively. The positive predictive value was 56.5%, 70.3%
and 73.08% for CK-19, CK-20 and UPII. Combined use of CK-20
and UPII gave the highest negative predictive value and posi-
tive predictive value.3.2. Bacterial infection and gene expression
Effect of bacterial infection on the ck19, CK20 and UPII mRNA
level in bladder cancer patients is shown in Table 4. The level
of gene expression was higher in non-infected BC patients
than infected BC patients. With respect to bacterial infection,
p value for UPII mRNA level was >0.05, while p value for CK-19
and CK-20 mRNA levels were <0.05. So with respect to bacte-
rial infection, there was no significant difference in level of
UPII expression in BC patients, while there was statistical
significance in the level of CK19 and CK20 expression in
bladder cancer patients.everse primer An.temp (C) (bp)
ACTTGGTTCGGAAGTCA 58 102
TTCCAGGGTGCTTAAC 58 162
TCGAGGGAGTGTGG 58 120
ATAGGAATCCTTCTGAC 58 51
Table 2 e The positive rates for CK-19, CK-20 and UPII mRNA among study groups.
groups CK19 CK20 UPII
BC UTI N BC UTI N BC UTI N
N 19 12 7 19 12 7 19 12 7
SE 0.358 0.152 0.079 5.32 0.00 0.0 8.759 0.063 0.0
Median 0.07 0.06 0.01 0.680 0.00 0.00 3.10 0.01 0.00
p Value 0.58 0.015 0.008
Fig. 1 e Different expression levels of В-actin, CK-19, CK-20
and UPII mRNA in study groups.
Table 5 e Correlation between bacterial infection and
tumor grade and stage.
T1 T2 T3,4 GI GII GIII
Infected 1 4 5 0 0 9
Non-Infected 5 2 2 1 5 4
p Value 0.80 0.031
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To test the correlation between bacterial infection and tumor
progression, tumor grade and stage were compared with
respect to infection as it is shown in Table 5. We found that
bacterial infection was correlated to high tumor grade.Table 3 e Sensitivity and specificity for separate and combined
Sensitivity Specificity
CK20 57.89% 100%
CK19 47.37% 68.42%
UP II 63.1% 100%
CK20 þ UP II þ CK19 78.95% 68.42%
CK19 þ CK20 73.68% 68.42%
UP II þ CK19 63.16% 68.42%
Ck20 þ UPII 78.95% 100%
Table 4 e Correlation between bacterial infection and gene exp
Groups CK19
Infected Non infected Infected
N 10 9 10
SE 0.04 0.6 1.2
Median 0.05 0.67 0.44
p Value 0.027 0.008According to p value, with respect to bacterial infection, there
was no statistically significant difference (p > 0.05) between
tumor stages, while the difference was significant (p < 0.05)
between tumor grades.
3.4. Correlation between tumor grade and level of gene
expression
Considering the different tumor stages, the median expres-
sion of the three genes was elevated in the higher tumor
stages and lower tumor grades. With respect to tumor stages,
there was no statistical significance (p > 0.05) in the expres-
sion level of CK-19 and UPII, however a statistical significance
(p < 0.05) was disclosed in expression level of CK-20 as shown
in Table 6.
There was no statistically significant differences in the
expression level of the three markers with respect to tumor
grades (Table 7).
There was a significant difference in level of CK20 expres-
sion in bladder cancer patients among different tumor stages
(Tables 6 and 7).use of CK-19, CK-20 and UPII expression levels.
Negative predictive value Positive predictive value
100% 70.3%
60% 56.5%
100% 73.08%
71.43% 76.47%
70% 72.22%
66.67% 65%
100% 82.61%
ression level among bladder cancer patients.
CK20 UPII
Non infected Infected Non infected
9 10 9
10.8 2.4 16.1
6.2 1 7.5
0.110
Table 6 e Correlation between tumor grade & level of
gene expression.
Grades CK19 CK20 UPII
GII GIII GII GIII GII GIII
N 6 13 6 13 6 13
SE 1.0 0.06 4.02 6.2 20.5 16.1
Median 0.37 0.07 3.12 0.68 34.20 3.1
p-Value 0.368 0.831 0.481
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It's awell-established fact that gram-negative bacteria of E. coli
and K. pneumoniae are the most common pathogenic bacteria
causing UTI, a finding that entirely agree with our results. The
current results also pointed out that E. coli is the most com-
mon uropathogenic bacteria, which infects bladder cancer
patients. This finding copes with the suggestion of El-
Mosalamy, Salman [7] that urinary bladder infection by E.
coli may play a major additive and synergistic role during
bladder carcinogenesis. It is known that inflammation facili-
tates initiation and progression of malignancy through pro-
duction of inflammatory oxidants [24]. In our studywe found a
significant correlation between tumor grade and bacterial
infection, as bacterial infectionwasmore associatedwith high
grade tumors.
Results of antimicrobial susceptibility pattern of E. coli
isolates revealed that E. coli isolates were highly sensitive to
Imipenem and Amikacin (100%). However, high resistance
rate was reported for amoxicillin/clavulanate, followed by
trimethoprim/sulphamethoxazole and then other drugs.
Debnath, Das [25] reported that the E. coli resistance rates for
nitrofurantoin, amikacin, amoxycillin/clavulanic, ciprofloxa-
cin and piperacillin/tazobactum were 4%, 13%, 17%, 50% and
50%, respectively. Therefore, these results are somewhat
different from these of the present study. The possible reason
for this disagreement may be due to the difference in
geographical location, population response or misuse of
antibiotic in our locality.
All isolates of K. pneumoniae, were highly sensitive to Imi-
penem, Amikacin and Piperacillin/tazobactam, while the
resistance rates were 60% for Cefotaxime, Ceftazidime,
trimethoprim/sulphamethoxazole, Cipro-floxacin and Cipro-
floxacin and were 40% for Amoxicillin/clavulanate. This
result goes hand in hand with that of Vakilwala and Trivedi
[26] who reported that the resistance rate for Ceftazidime,Table 7 e Correlation between tumor stage and level of gene e
Groups CK19
T1 T2 T3,T4 T1
N 6 6 7 6 6
SE 0.77 0.021 1.09 3.03 0
Median 0.25 0.06 1.48 4.4 0
p-Value 0.43 0.04Ciprofloxacin and Trimethoprim/sulphamethoxazole were
60%; 48% and 80%, respectively.
Early diagnosis of bladder cancer is mandatory because
any delay in treatment has been shown to affect progression.
At present, cystoscopic examination and urine cytology
remain the primary methods for the initial evaluation of the
lower urinary tract lesions to rule out bladder cancer. How-
ever, cystoscopy is invasive andmay be ineffective in patients
with an indwelling catheter or active inflammation due to the
presence of abnormal appearance of the bladder mucosa,
whereas cytology has low sensitivity in low-grade papillary
disease. Additional lab-basedmarkers are needed to aid in the
evaluation of these lesions [8]. Genetic marker development
represents a promising direction for the diagnosis of bladder
cancer [27]. Highly sensitive real-time RT-PCR has already
shown its ability to differentiate between malignant and
benign tissue and also to determine the stage and grade of
tumor tissue [28].
CK-19 is expressed in normal urothelium and can be
measured in the urine when urothelial cells are exfoliated.
The current study showed that CK-19 is expressed in all group
members. We determined cutoff value which gives the high-
est sensitivity and specificity by the ROC curve. The sensitivity
of CK-19 mRNA level was 47.37% and specificity was 68.42%.
The obtained sensitivity agrees with the study of Hassanien,
Nossier [29] that showed a sensitivity of CK-19 of 31%, how-
ever the specificity was higher (100%). Other studies have
shown sensitivities ranging from 43% to 79% and specificities
ranging from 68% to 88% for CK-19 mRNA and protein [30,31].
The high false positive rates of around 40% indicate that
pathogenic bacteria may affect the reliability of considering
CK-19 as a marker for bladder cancer detection. Our results
showed that CK-19 mRNA level was significantly different
among BC patients with or without bacterial infection, while
no correlation was found between urinary CK-19 expression
level and tumor grade or tumor stage. The latter finding dis-
agrees with the results of El-Salahy [15], where he found sig-
nificant correlation between CK-19 expression level and
tumor grade and stage.
RCK20 are intermediate filaments expressed in epithelial
cells. In our study, CK20 is only expressed in BC group, with no
false positive results. This absolutely agrees with immuno-
logical and northern blot studies found that CK20 expression
was restricted primarily to gastrointestinal tissue, urothelial
cell carcinoma and merkel cells [32]. In the current study,
there was a statistically significant difference in CK-20 mRNA
level among BC, UTI and control groups. This finding isxpression.
CK20 UPII
T2 T3 T4 T1 T2 T3, T4
7
6 6 7
.27
50.5
16.6 4.57 46.6
.68
50.5
1.8 3.11 53
0.266
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shown sensitivities ranging from 65% to 90% and specificities
ranging from 67% to 90% for CK-20 mRNA [27]. On the other
hand, some authors reported that CK-20 has a very low
specificity [33]. Our results demonstrated that there was a
statistically significant decrease in CK-20 mRNA level in BC
patients with respect to bacterial infection and there was a
significant correlation of CK-20 expression with tumor stage.
Similarly, El-Salahy [15] reported a significant correlation be-
tween CK-20 mRNA expression and tumor stage. However,
there was no correlation with the tumor grade in the present
study, a finding which is not coping with the results of El-
Salahy [15] but is coping with Pu, Wang [8].
Uroplakins (UPs) are integral membrane proteins that are
synthesized as the major differentiation products of
mammalian urothelium. Olsburgh, Harnden [17] expression
of UPII genes is highly specific to urothelium and they sug-
gested that the tight differentiation-restricted expression of
uroplakin genes in normal urothelium is lost following ma-
lignant transformation.
UPII was detected in BC andUTI patients as they both cause
exfoliation of epithelia cells into urine, while it was not
detected in normal group.
We found the overall sensitivity of UPII was 63.1% and
specificity was 100%. Its sensitivity in transitional cell carci-
noma was 90% in our study. This copes with the suggestion
that UPII is a highly specificmarker for human TCC [17]. These
results agreewith those of (Kurahashi, Hara [34]) who reported
that UPII mRNA was reliable in early detection of bladder
cancer metastasis by testing its level in tissue and blood. We
found no significant correlation between UPII mRNA expres-
sion level and tumor grade or stage.
In the current study, the combined use of UPII and CK-20
gave a highest sensitivity (78%) and specificity (100%), than
the combination of the threemarkers together or eachmarker
alone. This implies that the combined use of the UPII and CK-
20 may be a reliable tool for detecting bladder cancer.
4.1. Conclusion
E. coli are the most predominant bacterial isolates among
bladder cancer patients. CK-19 urine marker has low speci-
ficity for bladder cancer detection. But CK-20 and UPII urine
markers show high specificity as they have different expres-
sion level in benign and malignant states. Combined use of
UPII and CK-20 could represent a promising noninvasive tool
for the detection of bladder cancer in urine for patients who
have both symptoms of UTI and cancer. So further studies e
with large individuals number e on the reliability of the
combination of these two markers are recommended.r e f e r e n c e s
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